Replies to Post #212125 onBiotech Values | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Replies to post #212125 on Biotech Values

Replies to #212125 on Biotech Values

08/16/17 10:05 AM

#213156 RE: DewDiligence #212125

(ADXS)—IOVA* doses first patient in cervical-cancer phase-2:

https://globenewswire.com/news-release/2017/08/16/1086553/0/en/Iovance-Biotherapeutics-Announces-First-Patient-Dosed-in-C-145-04-Phase-2-Trial-in-Cervical-Cancer.html

*f/k/a LBIO.